Carmelo O. Diaz, PA-C

Carmelo Diaz practices at Fresno Specialty Surgery Center, PC in Fresno, California.

Carmelo Diaz's NPI, 1326420217, was assigned on June 26, 2015. Carmelo Diaz holds Utah license 9453799-1206.

Carmelo Diaz's primary practice is Fresno Specialty Surgery Center, PC, at 6181 N Thesta St, Fresno, CA 93710 in Fresno County. The practice phone is (800) 991-6448.

Carmelo Diaz's primary practice is Fresno Specialty Surgery Center, PC in Fresno, California. The medical group on file is Skin and Cancer Institute. Dmand AI also links Carmelo Diaz to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Carmelo Diaz practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Carmelo Diaz's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Carmelo Diaz is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Carmelo Diaz's licenses on file in 2 states: Utah and California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, scalp rash and skin cyst among the conditions Carmelo Diaz treats.

CMS data shows 1,180 Medicare services from Carmelo Diaz across 12 procedure codes in 2024, for 217 Medicare patients. Medicare paid $48,113 for them. Every service was in an office.

CMS counts 217 Medicare patients who saw Carmelo Diaz in 2024. The largest group is 65 to 74, with 117 patients. 74% of them have high cholesterol, and 66% have high blood pressure. 67% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Carmelo Diaz's median patient age at 59, with 57% women.

In 2024, Carmelo Diaz wrote 1,209 Medicare Part D claims for 284 patients. 91% of them were for generic drugs. CMS names the drug for 1,016 of them, across 16 drugs with 11 or more claims each, at $534,833 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Carmelo Diaz for performance year 2024, reported as part of a group. Carmelo Diaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 302 general payments to Carmelo Diaz from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,368.